癌症免疫治疗中的单细胞多组学:从瘤异质性到个性化精确治疗
Jiayuan Le1,2,3,4,5, Yating Dian1,2,3,4,5, Deze Zhao6
1Department of Dermatology, Xiangya Hospital, Central South University, 87 Xiangya road, Changsha, Hunan, 410008, China.
Molecular cancer
|August 26, 2025
概括
单细胞多组技术为癌症异质性提供了深入的见解,改善了癌症免疫治疗和个性化治疗. 这些先进的方法对于精确瘤学和克服治疗耐药性至关重要.
科学领域:
- 癌症学
- 基因组学
- 免疫学
背景情况:
- 癌症免疫疗法已经改变了瘤学,但由于瘤的复杂性和异质性而面临挑战.
- 患者内部和患者之间的瘤异质性使个性化癌症治疗策略复杂化.
研究的目的:
- 审查用于剖析瘤异质性的单细胞多组技术的进展.
- 突出这些技术对癌症研究,免疫疗法和精确瘤学的影响.
主要方法:
- 单细胞测序技术包括基因组学,转录组学,表观组学,蛋白质组学和空间组学.
- 系统地检查癌症研究中的最新技术进步及其应用.
主要成果:
- 单细胞多组学提供了多层次的洞察力,了解单细胞分辨率的瘤生物学和免疫反应.
- 这些技术揭示了免疫逃生,治疗耐药性,并使新抗原的发现成为可能.
结论:
- 通过更深入地了解瘤异质性, 单细胞多组正在彻底改变精确瘤学.
- 这些技术将成为开发真正个性化的癌症治疗和最小残留疾病监测的核心.
相关概念视频
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K


